Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers - United States
doi 10.1089/gtmb.2011.0298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc


Related search